4.8 Article

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

Related references

Note: Only part of the references are listed.
Letter Geriatrics & Gerontology

Durability of SARS-CoV-2 IgG Antibody Among Residents in a Long-Term Care Community

Marcus D. Ruopp et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

Letter Medicine, General & Internal

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants

Yang Liu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Infectious Diseases

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

Yaniv Lustig et al.

Summary: The study found that healthcare workers vaccinated with Comirnaty showed reduced neutralising titres against the Gamma, Beta, and Delta variants, but the remaining neutralisation capacity may still be protective.

EUROSURVEILLANCE (2021)

Letter Medicine, General & Internal

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

Madhumita Shrotri et al.

LANCET (2021)

Article Medicine, General & Internal

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk et al.

Summary: Among fully vaccinated health care workers, breakthrough infections with SARS-CoV-2 were correlated with neutralizing antibody titers during the peri-infection period. Most breakthrough infections were mild or asymptomatic, although persistent symptoms did occur.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine - in a Nationwide Mass Vaccination Setting

Stefan Roest et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality

Josef Coresh et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)